Today the biosimilar is a hospital reality that no one dares to contradict. Six experts representing the agents involved in this field pointed out the need to encourage the introduction of the biosimilar in the National Health System (SNS). This was revealed in the debate promoted by the employers Biosim and Fundamed under the title 'Biosimilar medicines. Exploring access routes to innovation in the Community of Madrid'.